More recently, EGFRvIII‐targeted CAR‐T cells were constructed to secrete engagers against wild‐type EGFR for local recruitment of bystander T cells against EGFRvIII‐negative tumour cell subpopulations in glioblastoma, so as to overcome the limitation of antigen escape.106. This evidence concerns the gene EGFR and glioblastoma.